---
title: "VIGL.US (VIGL.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VIGL.US/news.md"
symbol: "VIGL.US"
name: "VIGL.US"
parent: "https://longbridge.com/en/quote/VIGL.US.md"
datetime: "2026-03-10T04:21:33.007Z"
locales:
  - [en](https://longbridge.com/en/quote/VIGL.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VIGL.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VIGL.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/VIGL.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/VIGL.US/news.md)


# VIGL.US (VIGL.US) — Related News

### [07:53 ETBioVigil's Automated Hand Hygiene Monitoring Drives Meaningful and Sustained HAI Reduction](https://longbridge.com/en/news/277043991.md)
*2026-02-26T12:53:56.000Z*
> BioVigil's automated hand hygiene monitoring has led to a 46.95% reduction in healthcare-associated infections (HAIs) am

### [08:36 ETSonorous Neurovascular Receives FDA Breakthrough Device Designation for BosSTENT™, First Braided Self-Expanding Cerebral Venous Stent, to Treat Debilitating Pulsatile Tinnitus](https://longbridge.com/en/news/274983325.md)
*2026-02-05T13:37:16.000Z*
> Sonorous Neurovascular has received FDA Breakthrough Device Designation for its BosSTENT™, the first braided self-expand

### [Key facts: Sanofi acquires Vigil Neuroscience for $470 million; Formycon shares rise 8%](https://longbridge.com/en/news/266288325.md)
*2025-11-18T02:03:17.000Z*
> Sanofi acquired Vigil Neuroscience for $470 million, with a potential $600 million contingent payment, to develop a firs

### [Sanofi Finalizes Acquisition of Vigil Neuroscience to Boost Neurology Pipeline](https://longbridge.com/en/news/252081577.md)
*2025-08-07T16:57:31.000Z*
> Sanofi has completed its acquisition of Vigil Neuroscience for approximately $470 million, enhancing its neurology pipel

### [Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.](https://longbridge.com/en/news/251764362.md)
*2025-08-06T06:09:48.000Z*
> Sanofi completes the acquisition of Vigil Neuroscience, Inc. Paris, August 6, 2025. Sanofi announces the completion of i

### [Vigil Neuroscience | 10-Q: FY2025 Q2 EPS Misses Estimate at USD -0.56](https://longbridge.com/en/news/251617479.md)
*2025-08-05T10:47:39.000Z*
### [Vigil Neuroscience, Inc. (NASDAQ:VIGL) Sees Significant Growth in Short Interest](https://longbridge.com/en/news/251314115.md)
*2025-08-03T06:59:36.000Z*
> Vigil Neuroscience, Inc. (NASDAQ:VIGL) experienced a significant increase in short interest, rising 314.3% to 447,400 sh